The North America CAR-T Cell Therapy Market is supported by a growing ecosystem of biotechnology companies, pharmaceutical manufacturers, academic institutions, and specialized treatment facilities. Manufacturing networks are being developed to coordinate patient-specific cell processing and product delivery across wider geographic areas. Centralized facilities can support standardized...